Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Pegtomarginase |
Synonyms | |
Therapy Description |
Pegtomarginase is a modified form of the enzyme arginase linked to polyethylene glycol, which may lead to decreased arginine levels in the blood resulting in inhibition of cancer cell proliferation (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Pegtomarginase | A20CL|PT01|PT-01|PT 01 | Pegtomarginase is a modified form of the enzyme arginase linked to polyethylene glycol, which may lead to decreased arginine levels in the blood resulting in inhibition of cancer cell proliferation (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04136834 | Phase I | Pegtomarginase | A Phase I Open-label Study for Subjects With Advanced Malignancies (PT01) | Unknown status | USA | 0 |